U.S. Markets open in 17 hrs, 3 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,577.91 | -733.08 | -7.87% |
| NASDAQ | 1,628.33 | -150.68 | -8.47% |
| S&P 500 | 907.84 | -90.17 | -9.03% |
| Day Low 03:58 PM EDT | 12.56 | |
|---|---|---|
| Day High 09:30 AM EDT | 13.80 |
|
| Range | 1.24 | |
| Volume | 1.3 M | |
| 30-Day Avg. Vol. | 1.14 M |
|
| Difference | 14.46% | |
| Market Cap. | 1.21 B | |
| Change | -120.51 M | |
| Shares Out. | 95.64 M | |
| Percent Traded | 1.36% | |
| Revenue (LFY) | 69.62 M | |
| Earnings (TTM) | -136.3 M | |
| Next Earnings | 11/03/2008 |
|
| EPS (TTM) | -1.41 |
| 52-Wk Low 5/7/08 | 10.91 | |
|---|---|---|
| 52-Wk High 1/8/08 | 20.15 |
|
| Range | 9.24 | |
| Prev. Close 10/14/08 | 13.97 | |
| Today's Open | 13.80 | |
| Change | -1.22% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 1.5401 | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | -66.00 |
Blogs are not currently available for isis.
Isis Pharmaceuticals is trying to make sense out of antisense. The biotechnology company is developing drug therapies based on antisense technology, in which drugs attach themselves to strands of RNA in ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.051 11/3/08 | — — |
—
—
|
| Last Quarter | -0.05 6/30/08 | -0.02 6/30/08 |
0.03
Beat
|
| 2 Quarters Ago | -0.096 3/31/08 | -0.05 3/31/08 |
0.046
Beat
|
| Quarterly - 06/30/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 32.96 M | 69.62 M |
| Gross Profit | — | 63.00 M |
| Operating Income | -3.13 M | -38.95 M |
| Net Income | -2.21 M | -136.30 M |
